HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on CollPlant Biotechnologies (NASDAQ:CLGN) and maintained an $11 price target for the company's stock.
November 30, 2023 | 11:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms a Buy rating on CollPlant Biotechnologies with a maintained price target of $11.
The reiteration of a Buy rating and the maintenance of a price target by a reputable analyst typically instill confidence in investors and can lead to a positive short term impact on the stock price. The specific mention of the company and the reaffirmation of the price target suggest a strong belief in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100